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The lineage fate of developing thymocytes is deter-
mined by the persistence or cessation of T cell
receptor (TCR) signaling during positive selection,
with persistent TCR signaling required for CD4
lineage choice.We show here that transcriptional up-
regulation of CD4 expression is essential for error-
free lineage choice during major histocompatibility
complex class II (MHC II)-specific positive selection
and is critical for error-free lineage choice in TCR-
transgenic mice whose thymocytes compete for
the identical selecting ligand. CD4 upregulation
occurred for endogenously encoded CD4 corecep-
tors, but CD4 transgeneswere downregulated during
positive selection, disrupting MHC II-specific TCR
signaling and causing lineage errors regardless of
the absolute number or signaling strength of trans-
genic CD4 proteins. Thus, the kinetics of CD4 core-
ceptor expression during MHC II-specific positive
selection determines the integrity of CD4 lineage
choice, revealing an elegant symmetry between co-
receptor kinetics and lineage choice.
INTRODUCTION
The fate of T cells developing in the thymus is determined by the
specificity of their T cell antigen receptor (TCR). Thymocytes at
the CD4+CD8+ (double positive [DP]) stage of development are
the first cells in the thymus to express fully assembled abTCR
complexes and undergo either positive selection or cell death
(Starr et al., 2003). Positively selected DP thymocytes ultimately
differentiate into either CD4+ helper or CD8+ cytolytic T cells,
with thymocytes bearing TCR specific for major histocompati-
bility complex class II (MHC II) ligands differentiating into CD4+
helper T cells and thymocytes bearing TCR specific for MHC I
ligands differentiating into CD8+ cytolytic T cells (Starr et al.,
2003). The cellular and molecular mechanisms by which posi-
tively selected thymocytes determine the ligand specificity of
their TCR and their appropriate lineage fate have been the480 Immunity 31, 480–490, September 18, 2009 ª2009 Elsevier Inc.subject of intense investigation for years but have recently
been clarified (Hedrick, 2008; Singer et al., 2008).
It is now understood that TCR-mediated positive-selection
signals induce CD4+CD8+ double positive (DP) thymocytes to
downregulate CD8 coreceptor expression and to convert into
CD4+CD8lo intermediate thymocytes (Bosselut et al., 2003;
Brugnera et al., 2000). Positively selected CD4+CD8lo interme-
diate thymocytes then differentiate into either CD4 or CD8
lineage T cells on the basis of whether TCR signaling persists
or ceases (Brugnera et al., 2000; Sarafova et al., 2005; Singer,
2002; Singer and Bosselut, 2004; Yasutomo et al., 2000). Persis-
tent TCR signaling induces intermediate thymocytes to upregu-
late expression of ThPOK, the CD4-lineage-specifying transcrip-
tion factor, and to differentiate into CD4+ helper T cells (He et al.,
2005; He et al., 2008; Sun et al., 2005), whereas cessation of TCR
signaling results in expression of RUNX3, a CD8 lineage-speci-
fying transcription factor, and differentiation of intermediate
thymocytes into CD8+ cytolytic T cells (Setoguchi et al., 2008;
Taniuchi et al., 2004). Thus, CD4 lineage choice requires persis-
tent TCR signaling, whereas disrupted TCR signaling results in
CD8 lineage choice (Sarafova et al., 2005; Singer, 2002; Singer
and Bosselut, 2004; Singer et al., 2008).
Because CD4 and CD8 coreceptors stabilize and enhance
MHC-specific TCR signals, quantitative changes in surface cor-
eceptor expression during positive selection may affect TCR
signaling duration and, consequently, CD4-CD8 lineage choice.
Indeed, surface CD8 coreceptor expression declines on posi-
tively selected thymocytes as a result of decreased CD8 gene
transcription, disrupting MHC I-specific TCR signaling and
promoting CD8 lineage choice (Bosselut et al., 2003; Cibotti
et al., 2000). In contrast to the kinetics of CD8 coreceptor
expression during positive selection, which is well understood,
it is not known whether surface CD4 coreceptor expression
changes during positive selection and whether such changes
affect the duration of MHC II-specific TCR signaling to contribute
to CD4 lineage choice. Curiously, past experiments with trans-
genic CD4 coreceptors revealed that persistent CD4 coreceptor
expression had a paradoxical impact on lineage choice in that it
resulted in the aberrant generation of MHC II-specific CD8+
T cells (Davis et al., 1993). These studies were interpreted as
supportive of the stochastic-selection model of CD4-CD8
lineage choice, but subsequent experimental data make the
existence of a stochastic mechanism underlying CD4-CD8
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Coreceptor Kinetics and CD4 Lineage ChoiceFigure 1. MHC II-Specific Lineage Choice Is Highly
Error Prone in CD4 Transgenic Mice
(A) Phenotype of MHC II-selected LN T cells in mice ex-
pressing endogenous or transgenic CD4 coreceptor
proteins. MHC II-selected lymph node (LN) T cells from
three different strains of CD4 transgenic mice (CD4hCD2,
CD4T3, and 8DP4) and from mice expressing endoge-
nously encoded CD4 (CD4endo) proteins were analyzed
for CD4 and CD8 coreceptor expression (top row). Where
indicated, mice also expressed the AND TCR transgene
(Va11+Vb3+, bottom row). Boxes identify CD8+ LN
T cells and their relative frequencies. Data are representa-
tive of five independent experiments.
(B) Surface CD4 coreceptor expression changes during
MHC II-specific positive selection in the thymus. Thymo-
cytes from the indicated mice were analyzed for cell-
surface expression of CD4, CD8a, TCRb, and the CD4
reporter protein (CD4r) hCD2 (Figure S1). TCR-signaled
thymocytes were defined as TCRbhi cells, with signaled
DP thymocytes identified as TCRhiCD4r+CD8+ cells, inter-
mediate thymocytes (INT) identified as TCRhiCD4r+CD8lo
cells, and CD4 single-positive (CD4SP) thymocytes identi-
fied as TCRhiCD4r+CD8 cells (middle column). Each
signaled thymocyte population was then drawn individu-
ally, and histograms of all three thymocyte populations
were overlaid on an expanded ‘‘y’’ scale, as indicated by
the brackets (right column). CD4 surface expression on
each thymocyte population was quantified as MFI with
CD4 MFI on signaled DP thymocytes shown, and the
change in CD4 surface expression (DCD4) between
TCR-signaled DP and INT thymocytes was calculated
and expressed as ‘‘% change’’ according to the following
formula: % change = 100 3 (MFIINT  MFIDP)/(MFIDP).
Data are representative of four independent experiments.
(C) Kinetics of CD4 expression during MHC II-specific
positive selection and its relationship to MHC II-specific
lineage choice. CD4 expression on intermediate and
CD4SP thymocytes was normalized to CD4 expression
on signaled (i.e., TCRbhi) DP thymocytes—which was set
equal to 100%—from the same mouse (left panel). The
frequency (± standard error [SE]) of SP thymocytes that
were CD8SP in each mouse is displayed (right panel).
The numbers of mice analyzed per strain were as follows:
CD4endo = 10, 8DP4 = 10, and 8DP4+CD4endo = 2.lineage choice no longer tenable (Adoro et al., 2008; Itano and
Robey, 2000; Singer et al., 2008). Consequently, the paradoxical
observation that expression of transgenic CD4 coreceptors
induced a number of MHC II-specific thymocytes to differentiate
into CD8+ T cells remains unexplained.
The present study was undertaken to determine whether
surface CD4 coreceptor expression undergoes changes during
MHC II-specific positive selection and whether such changes
affect lineage choice. We now report that endogenous CD4 cor-
eceptor expression is in fact upregulated on MHC II-signaled
thymocytes during positive selection and that such CD4 upregu-
lation is essential for error-free lineage choice, regardless of the
absolute number or signaling strength of the CD4 coreceptors. In
the absence of CD4 upregulation,MHC II-specific lineage choice
is highly error prone, a situation exacerbated in TCR transgenic
mice whose thymocytes compete for a single selecting ligand.
Thus, the kinetics of CD4 coreceptor expression during positive
selection determines the integrity of CD4 lineage choice, com-
plementing what is known about the kinetics of CD8 coreceptorIexpression to reveal an elegant symmetry between coreceptor
kinetics and lineage choice.
RESULTS
To examine changes in CD4 coreceptor expression during MHC
II-specific positive selection and their effect on MHC II-specific
lineage choice, we compared MHC II-specific selection in mice
that expressed CD4 coreceptor proteins under the control
of either endogenous or transgenic transcriptional regulatory
elements (Figure 1). To generate experimental mice for this
study, we introduced transgenes encoding CD4 protein under
the control of the human CD2 promoter (CD4hCD2) (Van Laethem
et al., 2007), the human CD3d promoter (CD4T3) (Davis et al.,
1993; Lee et al., 1992), or the murine E8III enhancer plus CD8a
promoter (8DP4) (Ellmeier et al., 1998; Sarafova et al., 2005)
into B2m/Cd4/ so that only MHC II-selecting elements
and only transgenic CD4 coreceptor proteins were expressed
in the thymus (see Table S1 available online).mmunity 31, 480–490, September 18, 2009 ª2009 Elsevier Inc. 481
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encoded CD4 proteins (CD4endo), MHC II-specific selection re-
sulted exclusively in CD4+ T cells, indicating that MHC II-specific
lineage choice was error free (Figure 1A, upper-left panel). In
contrast, MHC II-specific lineage choice in CD4hCD2 and CD4T3
transgenic mice was error prone given that they contained
substantial frequencies (13% and 5%) of CD8+ lymph node
(LN) T cells (Figure 1A, upper-middle panels). CD8+ LN T cells
in CD4hCD2 and CD4T3 mice appeared as CD4+CD8+ because
transgenic hCD2 and hCD3d transcriptional control elements re-
mained active in CD8+ T cells (Figure 1A, upper-middle panels).
Notably, lineage errors did not require persistent CD4 transgene
expression because MHC II-specific selection was even more
error prone in a transgenic mouse (8DP4) in which transgenic
CD4 expression was terminated early during positive selection
(Figure 1A, upper-right panel). Error-prone MHC II-specific
lineage differentiation in 8DP4 mice resulted in mature T cells
that were phenotypically CD4 and appeared as either CD4
CD8 or CD4CD8+ cells (Sarafova et al., 2005). Thus, MHC
II-specific lineage choice was error free in nontransgenic mice
but was error prone in all three of the CD4 transgenic mice exam-
ined despite marked differences in duration of CD4 transgene
expression. Similarly, MHC II-specific lineage choice by mono-
clonal AND thymocytes (Kaye et al., 1989), which are Va11+
Vb3+, resulted only in CD4+ T cells when AND thymocytes ex-
pressed endogenously encoded CD4 coreceptor proteins but
was highly error prone when AND thymocytes expressed trans-
gene-encoded CD4 coreceptor proteins (Figure 1A, bottom
panels).
To understand the basis for error-free versus error-prone CD4
lineage choice, we considered that CD4 lineage choice requires
MHC II-specific TCR signaling to persist during differentiation of
signaled DP thymocytes into CD4+CD8lo intermediate thymo-
cytes, whereas any disruption in TCR signaling during this devel-
opmental step results in CD8 lineage choice (Brugnera et al.,
2000; Singer, 2002). Consequently, we quantified changes in
surface CD4 expression during differentiation of signaled DP
thymocytes into CD4+8lo intermediate cells. We identified
signaled DP thymocytes and intermediate cells without relying
on surface CD4 coreceptor expression by introducing into all
mice a CD4 reporter (CD4r) transgene that reports endogenous
Cd4 transcriptional activity by surface expression of hCD2
proteins (Figure S1) (Sawada et al., 1994). Specifically, MHC II-
signaled DP thymocytes were identified as TCRhiCD4r+CD8+
cells; intermediate thymocytes were identified as TCRhiCD4r+
CD8lo cells; and CD4SP thymocytes were identified as TCRhi
CD4r+CD8 cells.
We first examined thymocytes from 8DP4 mice because the
8DP4 transgene was transcriptionally regulated by E8III-CD8a
enhancer elements so that TCR signaling downregulated CD4
surface expression and disrupted MHC II signaling during differ-
entiation of DP into intermediate thymocytes (Sarafova et al.,
2005). As shown in a representative experiment, surface expres-
sion of 8DP4-encoded CD4 proteins was dramatically reduced
(88%) during differentiation of signaled DP into intermediate
thymocytes as CD4 mean fluorescent intensity (MFI) declined
from 132 to 16 (Figure 1B, upper panels), a change best appre-
ciated in the expanded view that was generated by gating indi-
vidually on each thymocyte subset and overlaying their profiles482 Immunity 31, 480–490, September 18, 2009 ª2009 Elsevier Inc.(Figure 1B, upper-right panel). In marked contrast to 8DP4-en-
coded CD4 proteins, surface expression of endogenously en-
coded CD4 proteins substantially increased (+61%) during
differentiation of signaled DP into intermediate thymocytes as
CD4 MFI increased from 450 to 725 (Figure 1B, middle panels).
To determine whether such changes in CD4 expression during
MHC II-specific positive selection affected the integrity of CD4
lineage choice, we assessed the frequency of MHC II-selected
CD8+ single-positive (SP) thymocytes (Figure 1C, right). We
found that B2m/ mice expressing 8DP4-encoded CD4
proteins contained a high frequency of MHC II-selected
CD8SP thymocytes, whereas B2m/ mice expressing endoge-
nously encoded CD4 proteins were essentially devoid of CD8SP
thymocytes (Figure 1C, right). Thus, endogenous CD4 surface
expression increased during differentiation of MHC II-signaled
DP into intermediate thymocytes and was associated with
error-free CD4 lineage choice, whereas 8DP4-encoded CD4
surface expression decreased on MHC II-signaled thymocytes
and was associated with error-prone CD4 lineage choice (Fig-
ure 1C, left and right panels).
To determine whether CD4 lineage choice was error prone in
8DP4 mice because CD4 expression was downregulated on
MHC II-signaled thymocytes and not because of 8DP4 trans-
gene expression per se, we generated B2m/ mice that ex-
pressed both the 8DP4 transgene and endogenously encoded
CD4 proteins (referred to as 8DP4+CD4endo mice). Examination
of 8DP4+CD4endo thymocytes mice revealed that surface CD4
expression increased (+52%) during differentiation of MHC II-
signaled DP into intermediate thymocytes (Figure 1B, last row)
because upregulation of endogenous CD4 proteins more than
compensated for decreased expression of 8DP4-encoded
CD4 proteins during MHC II-specific positive selection given
that CD4 MFI increased from 614 to 933 (Figure 1B, last row).
Importantly, we found that 8DP4+CD4endo mice were essentially
devoid of CD8SP thymocytes (Figure 1C), revealing that CD4
lineage choice in 8DP4+CD4endo mice was error free despite
expression of the 8DP4 transgene.
Basis for Error-Prone CD4 Lineage Choice in CD4
Transgenic Mice
On the basis of our findings in 8DP4mice that the kinetics of CD4
expression duringMHC II-specific positive selection affects CD4
lineage choice, we predicted that error-prone CD4 lineage
choice in CD4 transgenic mice might be due to a failure of trans-
genic CD4 proteins to be upregulated during MHC II-specific
positive selection. To assess this prediction, we quantified
changes in surface CD4 expression on DP and intermediate
thymocytes from CD4hCD2 and CD4T3 transgenic mice, including
an independently derived subline of CD4T3 (CD4T3L2) with lower
overall CD4 protein expression (Figure 2A, and Figure S2).
Although surface expression of endogenously encoded CD4
proteins increased during differentiation of signaled DP into
intermediate thymocytes, transgene-encoded CD4 expression
decreased in CD4hCD2, CD4T3, and CD4T3L2 mice (Figure 2A).
A summary of changes in CD4 expression during differentiation
of MHC II-signaled DP thymocytes from the various mouse
strains is displayed (Figure 2B, upper-left panel), along with
frequencies of ab LN T cells that had adopted the incorrect
CD8 lineage fate (Figure 2B, right panel). In fulfillment of our
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expression of endogenously encoded CD4 proteins increased
during differentiation of MHC II-signaled DP thymocytes into
intermediate cells and resulted in error-free lineage choice,
surface expression of transgene-encoded CD4 proteins
decreased and resulted in error-prone MHC II-specific lineage
choices (Figure 2B). Surprisingly, MHC II-specific lineage choice
was error prone in all CD4 transgenic mice even though overall
CD4 expression on transgenic thymocytes varied widely,
ranging from relatively high CD4 expression (CD4hCD2) to in-
termediate CD4 (CD4T3) to low CD4 expression (CD4T3L2)
(Figure 2B, Figure S2B). Thus, regardless of the overall quantity
of CD4 coreceptor expression on thymocytes, downregulation
of surface CD4 expression during differentiation of signaled
DP into intermediate thymocytes results in error-prone MHC
II-specific lineage choice.
We also determined CD4 expression on signaled DP and inter-
mediate thymocytes from CD4T3 (B2m/) mice expressing both
Figure 2. Coreceptor Kinetics and Lineage Choice
in CD4 Transgenic Mice
(A) Quantitation of CD4 expression during MHC II-specific
positive selection. Thymocytes were analyzed for cell-
surface expression of CD4, CD8a, TCRb, and the CD4
reporter protein (CD4r) (see Figures S2–S4). CD4 surface
expression on signaled (TCRbhi) DP, INT, and CD4SP
thymocyte populations in each mouse were analyzed as
in Figure 1B, with relative changes in CD4 surface expres-
sion between TCR-signaled DP and intermediate thymo-
cytes quantitated as % change. Data are representative
of four independent experiments.
(B) Coreceptor kinetics and its relationship to MHC II-
specific lineage choice in CD4 transgenic mice. Surface
expression of CD4 (± SE) (left upper panel) and hCD2
reporter protein (left lower panel) on intermediate and
CD4SP thymocytes from individual mice were expressed
relative to CD4 expression on signaled (TCRbhi) DP thymo-
cytes—which was set equal to 100% and so does not
vary—from each individual mouse (left upper panel).
Error-prone lineage choice is indicated by the frequency
(±SE) of LN T cells that are CD8+ for each strain (right
panel). The numbers of mice analyzed per strain were as
follows: CD4endo = 10, CD4hCD2 = 7, CD4T3L1 = 6, and
CD4T3L2 = 4.
(C) Coreceptor kinetics and its relationship to MHC II-
specific lineage choice in B2m/ mice expressing
CD4endo and CD4T3 proteins. Surface expression of CD4
(± SE) (left panel) on intermediate and CD4SP thymocytes
from individual mice were expressed relative to CD4
expression on signaled (TCRbhi) DP thymocytes—which
was set equal to 100%—from each individual mouse (left
panel) (see Figures S2–S4). Error-prone lineage choice is
indicated by the frequency (± SE) of LN T cells that are
CD8+ for each strain (right panel). The numbers of mice
analyzed per strain were as follows: CD4endo = 10 and
CD4endo+CD4T3 = 4.
endogenous and transgenic CD4 proteins,
because we thought that transcriptional upre-
gulation of endogenous CD4 proteins during
MHC II-specific positive selection might be
counterbalanced by downregulation of trans-
genic CD4T3 proteins. In fact, in CD4T3 (B2m/)
mice, overall CD4 surface expression remained essentially
unchanged during differentiation of signaled DP into interme-
diate thymocytes, as well as during their subsequent differentia-
tion into CD4SP cells (Figure 2C, left panel). MHC II-specific
lineage choice in these mice was also error prone as revealed
by both the frequency of ab LN T cells that were CD8+
(Figure 2C, right panel) and the presence in the thymus of
HSATCRbhiCD8+ thymocytes (Figures S3 and S4). These
results indicate that failure to upregulate surface CD4 expression
during differentiation of signaled DP into intermediate thymo-
cytes is sufficient for error-prone MHC II-specific lineage choice.
Because endogenous and transgenic CD4 proteins were tran-
scriptionally regulated by different regulatory elements, the
unique upregulation of endogenous CD4 proteins during MHC
II-specific positive selection must have been the result of
increased Cd4 gene transcription. To verify that the transcription
of endogenous Cd4 genes in signaled thymocytes increased
during MHC II-specific positive selection, we quantified surfaceImmunity 31, 480–490, September 18, 2009 ª2009 Elsevier Inc. 483
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endogenous Cd4 gene activity. In fact, expression of CD4r-
encoded hCD2 proteins was upregulated on signaled TCRhi
thymocytes (Figure 2B, lower-left panel), indicating that Cd4
gene transcription progressively increased in signaled thymo-
cytes throughout MHC II-specific positive selection.
Error-Prone CD4 Lineage Choice and RUNX3
Expression
Because CD8 lineage choice is specifically associated with
upregulation of the transcription factor RUNX3 (Egawa et al.,
2007; Sato et al., 2005; Setoguchi et al., 2008; Taniuchi et al.,
2002), whereas CD4 lineage choice is associated with upregula-
tion of the transcription factors ThPOK (He et al., 2005; Sun et al.,
2005), TOX (Aliahmad and Kaye, 2008; Wilkinson et al., 2002),
and GATA3 (Hernandez-Hoyos et al., 2003; Wang et al., 2008),
we quantified expression of these transcription factors in purified
intermediate thymocytes during MHC II-specific positive selec-
tion (Figure 3). As expected, expression of the CD4 lineage-
associated factors ThPOK, TOX, and GATA3 was upregulated
during differentiation of DP into intermediate thymocytes in all
mice examined (Figure 3), with the extent of upregulation greater
in intermediate thymocytes expressing higher CD4 as a result of
quantitatively stronger MHC II-specific positive-selection signal-
ing (Figure 3). In contrast to induction of CD4 lineage-associated
factors, MHC II-specific positive selection does not normally
induce RUNX3 expression, and we confirmed this point in inter-
mediate thymocytes fromB2m/mice expressing only CD4endo
coreceptors (Figure 3). Importantly, however, RUNX3 expression
was upregulated in MHC II-selected intermediate thymocytes
from mice expressing CD4hCD2 or CD4endo+CD4T3 coreceptors
(Figure 3), i.e., only those mice in which MHC II-specific lineage
choice was error prone as revealed by the presence of
HSATCRbhiCD8+ thymocytes (Figures S3 and S4) and CD8+
LN T cells (Figures 2B and 2C; Figure S4). Notably, the relatively
low expression of RUNX3 in intermediate thymocytes from mice
expressing CD4hCD2 or CD4endo+CD4T3 coreceptors (Figure 3) is
consistent with induction of RUNX3 expression only in those
intermediate thymocytes making an erroneous lineage choice.
Thus, failure of MHC II-specific positive selection to upregulate
surface CD4 expression during differentiation of DP into interme-
diate thymocytes results in induction of the CD8 lineage-associ-
ated factor RUNX3 in intermediate thymocytes and generation of
erroneous MHC II-specific CD8+ T cells.
CD4 Coreceptor Signal Strength Does Not Affect
the Integrity of CD4 Lineage Choice
Next, we examined whether CD4 coreceptor signal strength
affected the integrity of CD4 lineage choice, because it has
been suggested that CD4 lineage choice is driven by strong cor-
eceptor signals transduced by the CD4 cytosolic tail (Itano et al.,
1996). Consequently, we assessed whether modifications to the
cytosolic tail of transgenic CD4 coreceptor proteins affected
lineage choice. We compared B2m/Cd4/ transgenic mice
expressing hCD2-driven CD4 transgenes that encoded re-engi-
neered CD4 proteins containing the cytosolic tail of CD4
(CD4hCD2), CD8a (4aahCD2), CD8b (4bbhCD2), or no tail at all
(44thCD2) (Figure S5A). Surface CD4 expression was roughly
comparable to that of endogenous CD4, with the exception of484 Immunity 31, 480–490, September 18, 2009 ª2009 Elsevier Inc.the 44thCD2 transgene, which displayed very high CD4 expres-
sion, because tailless CD4 proteins cannot be internalized from
the cell surface (Figure S5A). As we previously reported
(Van Laethem et al., 2007), the re-engineered CD4 proteins
displayed a distinct hierarchy of Lck binding such that corecep-
tors bearing the CD4 cytosolic tail bound the most Lck, corecep-
tors bearing the CD8a cytosolic tail bound less Lck, and
coreceptors bearing CD8b or no cytosolic tail bound no detect-
able Lck (Figure S5B). Notably, Lck binding determines CD4
signaling strength and had a substantial quantitative effect on
MHC II-specific positive selection, given that the frequency of
signaled TCRbhi thymocytes paralleled the CD4-Lck associations
ineachstrain (CD4hCD2>4aahCD2>4bbhCD2=44thCD2) (Figure4A).
However, regardlessofCD4signal strengthoroverallCD4expres-
sion, MHC II-specific lineage choice was error prone in all of
these CD4 transgenic mice, because each contained CD8+ LN
T cells (Figure 4A, right panels). Contrary to the strength-of-signal
Figure 3. Analysis of Lineage-Specifying Gene Expression during
Positive Selection
Expression of mRNAs specific for Runx3, ThPOK, Tox, and Gata3 were as-
sessed in flow-cytometry-sorted preselection DP (CD69TCRblo) thymocytes
and intermediate (INT; CD69+TCRbint/hi) thymocytes by quantitative real-time
PCR. Gene expression was normalized to Actb (b-actin) expression in the
same samples. Bar graphs (right) represent the fold increase in mRNA expres-
sion between DP and INT thymocytes from the same mice. Data are represen-
tative of two independent experiments.
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lated to CD4 Signal Strength
(A) Characterization of thymocytes and T cells in
mice expressing wild-type and re-engineered
CD4 coreceptor proteins. Re-engineered CD4
transgenes were named according to the origin
of their external, transmembrane, and cytosolic
domains as 4aa (with transmembrane and cyto-
solic domains of CD8a), 4bb (with transmembrane
and cytosolic domains of CD8b), and 44t (with no
cytosolic tail) and were placed under the control
of transgenic hCD2 promoter and enhancer
elements. Thymocytes from mice expressing the
indicated transgenes were stained for CD4,
CD8a, and TCRb, and the frequency of positively
selected TCRbhi thymocytes is indicated (left
panels). CD4 surface expression on signaled DP,
INT, and CD4SP thymocyte populations from
each mouse strain was analyzed as in Figure 1B,
but only the expanded ‘‘y’’ scale view is presented.
Relative changes in CD4 surface expression
between TCR-signaled DP and intermediate
thymocytes were quantitated as % change. Right
panels display CD4 versus CD8 staining of LN
cells from the same individual mice, with the
frequency of CD8+ T cells in the LN of each mouse
indicated. Data are representative of three inde-
pendent experiments.
(B) Lineage choice is affected by CD4 kinetics, not
CD4 signal strength. CD4 surface expression on
intermediate and CD4SP thymocytes is expressed
relative to CD4 expression on signaled (TCRbhi)
DP thymocytes—which was set equal to 100%—
from each strain (left panel). Error-prone lineage
choice is indicated by the frequency (± SE) of LN
T cells that are CD8+ for each strain (right panel).
The numbers of mice analyzed per strain were as
follows: CD4hCD2 = 7, 4aahCD2 = 3, 4bbhCD2 = 4,
44thCD2 = 4, and CD4endo n = 10.perspective (Itano et al., 1996), CD4 lineage choice was not less
error prone with stronger-signaling CD4 coreceptors and was
not more error prone with weaker-signaling CD4 coreceptors
(Figure 4A, right panels as an example of one experiment). The
full course of all our experiments revealed that lineage choice
was error prone in CD4 transgenic mice regardless of CD4 signal
strength (Figure 4B, right panel). We then examined whether
CD4 coreceptor expression was up- or downregulated on MHC
II-signaled thymocytes in these mice (Figure 4B). In each of these
transgenic strains, we found that CD4 expression declined during
differentiationofMHC II-signaledDP into intermediate thymocytes
(Figure 4B, left) and was associated with CD8 lineage-choice
errors (Figure 4B, right). Thus, failure to upregulate CD4 during
positive selection caused lineagechoice tobeerror prone, regard-
less of CD4 signal strength or overall CD4 expression.
Competition for Ligand among TCR Transgenic
Thymocytes Exacerbates CD4 Lineage-Choice Errors
Finally, we wished to understand our early observation that
lineage choice was especially error prone in CD4hCD2 transgenic
mice that expressed the AND TCR transgene (AND.CD4hCD2Imice) (Figure 1A, bottom panels). Indeed, as compared to
CD4hCD2 mice with polyclonal TCR, MHC II-specific lineage
choice in AND.CD4hCD2 mice was excessively error prone, given
that nearly 50% of AND T cells in thymus and LN of
AND.CD4hCD2miceweremature CD8+ T cells (Figure 5, compare
rows 2 and 4). Note that the erroneous differentiation of
AND.CD4hCD2 thymocytes into CD8+ T cells occurred despite
their relatively homogeneous expression of Va11hiVb3hi trans-
genic AND TCR (Figure 5, lower panels). Consequently, we
considered that, unlike thymocytes with polyclonal TCR, AND
TCR transgenic thymocytes compete with one another for
binding to the identical peptide-MHC II-selecting ligand (Hues-
mann et al., 1991; Wong et al., 2000). However, ligand competi-
tion among AND thymocytes, in and of itself, was not an explana-
tion for error-prone lineage choice, because AND thymocytes in
mice expressing wild-type CD4endo coreceptors (AND.CD4endo)
contained no mature CD8+ AND T cells in either thymus or LN
(Figure 5, row2). Nevertheless, we reasoned that AND thymocyte
competition for a limiting ligand would exacerbate TCR signaling
disruptions caused by downregulation of transgenic CD4 core-
ceptors, increasing lineage-choice errors. If our reasoning ismmunity 31, 480–490, September 18, 2009 ª2009 Elsevier Inc. 485
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of cells in an individual thymus that expressed the AND TCR
would decrease ligand competition and make AND lineage
choice less error prone.
To test this prediction, we constructed radiation bone mar-
row (bm) chimeras in which lethally irradiated B2m/ (CD45.1)
host mice were reconstituted with donor bm stem cells
from B2m/Cd4/AND.CD4hCD2 (CD45.2) and nontransgenic
B2m/ (CD45.1) mice in varying ratios so that AND.CD4hCD2
(CD45.2) bm cells constituted 100%, 10%, or 1% of the mixed
donor bm inoculum (Figure 6A). Ten weeks after bm reconstitu-
tion, LN T cells from high frequency AND chimeras were 80%–
95% AND (CD45.2), LN T cells from medium-frequency AND
chimeras were 20%–45% AND, and LN T cells from low-
frequency AND chimeras were 1%–5% AND (Figure 6A and
data not shown). The relative frequency of AND T cells that erro-
neously differentiated into CD8+ T cells was not constant,
because the frequency of AND T cells that were CD8+ was rela-
tively high (35%) in chimeras with many AND (CD45.2) T cells but
was relatively low (7%) in chimeras with fewAND (CD45.2) T cells
(Figure 6A). In fact, the lineage error rate among AND.CD4hCD2
Figure 5. Expression of the AND TCR Exacerbates Lineage-Choice
Errors in CD4 Transgenic Mice
CD4 versus CD8 expression of mature, MHC II-selected T cells in the thymus
(left panels) and LNs (right panels) of B2m/ mice expressing endogenous
coreceptor proteins or B2m/Cd4/ mice expressing transgenic CD4 core-
ceptor proteins, and either polyclonal or AND TCR, as indicated. Bottom
panels display Va11 versus Vb3 expression of gated LN T cells. Boxes identify
CD4+ and CD8+ T cells and their relative frequencies. Data are representative
of five independent experiments.486 Immunity 31, 480–490, September 18, 2009 ª2009 Elsevier Inc.T cells was relatively low in chimeras in which fewer than 30%
of T cells expressed the AND TCR transgene but sharply
increased in chimeras in which more than 30% of T cells
expressed the AND TCR transgene (Figure 6B). In other words,
the frequency of lineage-choice errors among developing
AND.CD4hCD2 T cells was quantitatively affected by the number
of AND.CD4hCD2 thymocytes that simultaneously competed for
the same intrathymic selecting ligand. Thus, lineage choice is
strikingly error prone in AND.CD4hCD2 mice because ligand
competition exacerbates AND TCR signaling disruptions in
thymocytes that downregulate transgenic CD4 coreceptors
during MHC II-specific selection (schematized in Figure S6).
DISCUSSION
Kinetic changes in CD8 coreceptor expression during MHC
I-specific positive selection are important for CD8 lineage
choice, but the importance of CD4 kinetics for CD4 lineage
choice has not previously been appreciated. The present study
now reveals that transcriptional upregulation of CD4 coreceptor
Figure 6. Ligand Competition Increases Lineage-Choice Errors
among AND T Cells in CD4hCD2 Mice
(A)Mixed-donor radiation bonemarrow (bm) chimeraswere constructed by re-
constituting lethally irradiated (950R) B2m/ (CD45.1) mice with a total of 107
donor bm from B2m/Cd4/AND.CD4hCD2 (CD45.2) and B2m/ (CD45.1)
mice, such that AND.CD4hCD2 bm constituted 100%, 10%, or 1% of the total
bm inoculum. Ten weeks after reconstitution, LN cells were assessed for
surface expression of the indicated markers. Data represent five independent
experiments.
(B) Effect of ligand competition on error-prone lineage choice. The frequency
of donor AND (CD45.2) LN T cells that were CD8+ was plotted against the
frequency of AND (CD45.2) T cells in each chimera.
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CD4+CD8lo intermediate thymocytes is essential for error-free
CD4 lineage choice, especially in TCR transgenic mice whose
thymocytes compete for the identical selecting ligand. Indeed,
it is the kinetics of CD4 coreceptor expression, not CD4 corecep-
tor number or signaling strength, that determines the integrity of
CD4 lineage choice during MHC II-specific positive selection.
Together with current knowledge about the kinetics of CD8 cor-
eceptor expression during positive selection (Kioussis and Ell-
meier, 2002; Singer et al., 2008), the present study reveals that
TCR-mediated positive-selection signals downregulate CD8
but upregulate CD4 coreceptor expression, disrupting MHC
I-specific TCR signaling to promote CD8 lineage choice and pro-
longing MHC II-specific TCR signaling to promote CD4 lineage
choice.
The present study provides a new dimension to the kinetic
signaling perspective that CD4 lineage choice requires sustained
TCR signaling during differentiation of DP into CD4+CD8lo inter-
mediate thymocytes. CD4 upregulation during this develop-
mental step stabilizes MHC II-specific TCR-ligand interactions
so that TCR signaling persists to drive CD4 lineage choice. In
contrast, CD4 downregulation makes it difficult to sustain MHC
II-specific TCR-ligand interactions, so that TCR signaling disrup-
tions resulting in lineage-choice errors occur. Our current obser-
vation that error-free CD4 lineage choice requires CD4 upregula-
tion regardless of the absolute number or signaling strength of
the CD4 coreceptors emphasizes the difference between the
TCR signaling requirements for positive selection and the TCR
signaling requirements for CD4 lineage choice: the ability of indi-
vidual DP thymocytes to be signaled by their MHC II-specific
TCR to undergo positive selection is affected by the absolute
number and signaling strength of the CD4 coreceptors that
they express; however, once signaled to undergo positive selec-
tion, error-free differentiation into CD4+ T cells requires that CD4
expression further increase to maintain MHC II-specific TCR
signaling. In fact, because MHC II-specific TCR-ligand interac-
tions would be especially difficult to sustain in the absence of
CD4 coreceptor expression altogether, our present study readily
explains why lineage choice amongMHC II-signaled thymocytes
is so highly error prone in CD4-deficient mice (Matechak et al.,
1996; Tyznik et al., 2004).
The present study also provides a new dimension to our
understanding of ligand competition during thymic selection by
demonstrating that ligand competition can affect the integrity
of CD4 lineage choice byMHC II-specific TCR transgenic thymo-
cytes. Indeed, coreceptor kinetics explains why introduction of
the AND TCR transgene caused CD4 lineage choice to be strik-
ingly error prone in CD4 transgenic mice, but did not cause CD4
lineage choice to be error prone in CD4 wild-type mice (Wong
et al., 2000). In both CD4 transgenic and CD4 wild-type mice,
preselection AND thymocytes would compete with one another
for the same peptide-MHC II-selecting ligand, and only preselec-
tion AND thymocytes that successfully bound its selecting ligand
would be signaled to undergo positive selection. Importantly, in
CD4 wild-type mice, endogenous CD4 expression is upregu-
lated during positive selection so that signaled AND thymocytes
express more endogenous CD4 than unsignaled AND thymo-
cytes, with the result that unsignaled AND thymocytes cannot
out-compete signaled AND thymocytes for binding to the select-Iing ligand. But in CD4 transgenic mice, transgenic CD4 expres-
sion is downregulated during positive selection, so signaled AND
intermediate thymocytes express less transgenic CD4 than
unsignaled preselection AND thymocytes, with the result that
unsignaled AND thymocytes out-compete signaled AND thymo-
cytes for binding to the selecting ligand, disrupting AND TCR
signaling. Thus, in CD4 wild-type mice, endogenous CD4 upre-
gulation prevents ligand competition among AND thymocytes
from introducing lineage-choice errors; however, in CD4 trans-
genic mice, CD4 downregulation synergizes with ligand compe-
tition to make AND lineage choice strikingly error prone.
The CD4T3 transgene used in this study was reported in the
past to promote generation of MHC II-specific CD8+ T cells
and to support the stochastic-selection model of lineage choice
(Davis et al., 1993). It was thought that forced transgenic expres-
sion of CD4 coreceptors during positive selection rescued from
cell death short-lived MHC II-signaled thymocytes that had
stochastically made a CD8 lineage choice (Davis et al., 1993).
However, this explanation and the presumptions underlying the
stochastic-selection model have since been experimentally dis-
proved (Adoro et al., 2008; Dave et al., 1998; Itano and Robey,
2000; Sarafova et al., 2005; Singer et al., 2008), leaving the
generation of MHC II-specific CD8+ T cells in CD4T3 transgenic
mice unexplained. The present study now indicates that MHC
II-specific lineage choice is error prone in CD4T3 and other
CD4 transgenic mice because expression of transgenic CD4
coreceptors fails to be upregulated during MHC II-specific
positive selection, which leads to TCR signaling disruptions
and lineage-choice errors. Similarly, the appearance of MHC
II-selected CD8+ T cells in CD4-silencer-deficient mice was
also originally explained as revealing a stochastic mechanism
underlying lineage choice (Leung et al., 2001). However, deletion
of the CD4 silencer element additionally deleted cryptic CD4
enhancer elements transcriptionally active in signaled thymo-
cytes, because CD4 coreceptor expression on MHC II-signaled
thymocytes in CD4 silencer-deficient mice was reduced relative
to wild-typemice (Leung et al., 2001). In fact, careful examination
of published thymocyte profiles from these CD4 silencer-defi-
cient mice reveal that CD4 coreceptor expression dramatically
declined on signaled DP thymocytes during their differentiation
into CD4+8lo intermediate thymocytes, explaining why MHC
II-specific lineage choice was error prone in these animals.
Expression of endogenously encoded CD4 coreceptors is
transcriptionally upregulated during MHC II-specific selection,
but the molecular mechanism by which this occurs is not yet
clear. Transcriptional regulation of the endogenouos Cd4 gene
locus still remains incompletely understood (Ellmeier et al.,
1999; Leung et al., 2001), but we suspect that Cd4 enhancer
elements exist that increase Cd4 gene transcription in response
to TCR-mediated positive-selection signals. Even though the
existence of TCR-responsive enhancer elements in the Cd4
gene remain a matter of speculation, the transcription factor
Tox appears to be necessary for increasedCd4 gene expression
during positive selection, given that CD4 expression on signaled
thymocytes from Tox-deficient mice is downregulated, rather
than upregulated, during MHC II-specific selection (Aliahmad
and Kaye, 2008).
Finally, our conclusion that error-free CD4 lineage choice
requires CD4 upregulation to sustain MHC II-specific TCRmmunity 31, 480–490, September 18, 2009 ª2009 Elsevier Inc. 487
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selection, TCR-signaled CD4hiCD8hi (DPhi) thymocytes downre-
gulate expression of both CD4 and CD8 coreceptors to become
CD4loCD8lo (DPlo) thymocytes, which then differentiate into
CD4+CD8lo intermediate cells that ultimately differentiate into
either CD4+ or CD8+ T cells (Aliahmad and Kaye, 2008; He and
Kappes, 2006; Lucas and Germain, 1996; Sant’Angelo et al.,
1998). However, precursor-progeny assessments have never
actually documented that CD4+ T cells arise from DPlo thymo-
cytes that had previously been DPhi, and we do not think that
this is the phenotypic pathway by which mature CD4+ T cells
arise. Rather, we think that CD4 coreceptor expression is
constantly increasing on MHC II-signaled thymocytes, progres-
sively increasing the stability of MHC II-specific TCR-ligand
interactions and promoting error-free CD4 lineage choice. That
is, we think that MHC II-specific TCR signals induce newly
arising DPlo thymocytes to upregulate CD4 (and terminate
CD8) expression to become CD4+8lo intermediate thymocytes,
which then differentiate into mature CD4+ T cells. Consequently,
we consider DPhi thymocytes to be cells that have failed MHC
II-specific positive selection but might still be signaled by MHC I
ligands to differentiate into CD8+ T cells.
In conclusion, the kinetics of CD4 coreceptor expression
during MHC II-specific positive selection importantly influence
the integrity of CD4 lineage choice, especially in TCR transgenic
mice whose thymocytes compete for limiting ligand. Building on
current knowledge about the kinetics of CD8 coreceptor expres-
sion, this study reveals that coreceptor kinetics during positive
selection promote error-free CD8 lineage choice by disrupting
MHC I-specific TCR signaling and promote error-free CD4
lineage choice by prolonging MHC II-specific TCR signaling.
EXPERIMENTAL PROCEDURES
Animals and Transgenic Constructs
C57BL/6 (B6), B2m/, and Cd4/ mice were purchased from The Jackson
Laboratory (Bar Harbor, ME). B2m/Cd4/ double-deficient mice were
generated and bred to mice expressing the line 30 CD4 reporter transgene
(CD4r) from D. Littman (NYU) (Sawada et al., 1994). All CD4 transgenes in
the present study were expressed in B2m/Cd4/CD4r+ unless otherwise
indicated. The 8DP4 transgene has previously been characterized (Sarafova
et al., 2005) and expresses CD4 under the control of E8IIICD8a enhancer
and CD8a promoter elements (Ellmeier et al., 1998). CD4T3 transgenic mice
express CD4 under the control of hCD3d promoter-enhancer elements and
were constructed in our laboratory from a transgenic vector kindly provided
by D. Littman (Davis et al., 1993). The CD4hCD2 transgene expresses CD4
under the control of hCD2 promoter and enhancer elements, as previously
described (Van Laethem et al., 2007). A brief description of the CD4 transgenic
mice used in this study is provided (Table S1). Where indicated, mice also ex-
pressed the AND TCR transgene (Kaye et al., 1989). Mixed radiation bm
chimeras were constructed by reconstituting 950R irradiated host mice with
a total of 107 T-depleted bm cells from CD45.1 and CD45.2 donor mice. All
mice were cared for in accordance with National Institutes of Health (NIH)
guidelines and with the approval of the National Cancer Institute animal care
and use committee.
CD4 Transgenic Mice Expressing Re-engineered CD4 Proteins
with Different Cytosolic Tails
Re-engineered CD4 coreceptor proteins expressing different cytosolic tails
were generated from cDNAs encoding CD4, CD8a, and CD8b by conventional
cloning procedures. Amino acid sequences at the modified junctions were as
follows: 4aa ext/tm junction, VNQT/DIYIWAPLAGIC; 4bb ext/tm junction,
VNQT/DITTLSLL; and 44t tm/cyto junction, GLCILCCV/RCRHQQRQ. The re-488 Immunity 31, 480–490, September 18, 2009 ª2009 Elsevier Inc.sulting chimeric cDNAs were inserted into the hCD2-based cassette and
were used to generate transgenic mice, as previously described (Van Laethem
et al., 2007). Transgenic offspring were mated to B2m/Cd4/ mice or to
AND TCR transgenic B2m/Cd4/ mice. Transgenic offspring were identi-
fied by the presence of CD4+CD8+ cells in the blood. The absence of endog-
enous CD4 and b2m were confirmed by PCR. All mice in this study were
heterozygous for the transgene(s) they expressed.
Antibodies
Monoclonal antibodies with the following specificities were used in this study:
CD3 (145-2C11 PharMingen), CD4 (GK1.5, PharMingen), CD8a (CT-CD8 a,
Caltag), CD24 (M1-69, PharMingen), CD69 (H1.2F3, PharMingen), hCD2
(CD0215-4, Caltag), H-2Kb (AF6-88.5, PharMingen), TCRb (H57-597, PharMin-
gen), CD45.1 (A20, PharMingen), CD45.2 (104, PharMingen), TCR-Vb3 (KJ25,
PharMingen), and TCR-Va11 (RR8-1, PharMingen).
Flow Cytometry
CD4 fluorescence on TCR-signaled DP thymocytes (identified as TCRbhiCD4r+
CD8hi cells), intermediate thymocytes (identified as TCRbhiCD4r+CD8int cells),
and CD4SP thymocytes (identified as TCRbhiCD4r+CD8 cells) was either ex-
pressed as mean fluorescence intensity (MFI) or quantitated into linear total
fluorescence units (TFUs) with an empirically derived calibration curve con-
structed for each logarithmic amplifier. Relative CD4 expression on each cell
population was calculated relative to signaled DP thymocytes. To avoid fluo-
rescence compensation errors that might have affected our flow-cytometric
data, we verified that CD4 versus CD8 profiles from samples stained with
only two colors were always identical to CD4 versus CD8 profiles from multi-
color stained samples. In addition, three different fluorochrome combinations
were used for TCR versus CD4 versus CD8 staining so that results were repro-
ducible on differentmachineswith different lasers and different fluorochromes.
Immunoprecipitation and Immunoblotting
Thymocytes (2 3 107 cells/group) were solubilized in 1% Brij96, and CD4
molecules were immunoprecipitatedwith purified anti-CD4mAb (GK1.5, Phar-
Mingen) and protein G-sepharose beads. Whole-cell lysates and immunopre-
cipitates were resolved by SDS-PAGE on 10% acrylamide (Invitrogen) under
reducing conditions and transferred to nitrocellulose membranes (Amersham).
Blots were incubated with anti-Lck (3A5, PharMingen) and anti-actin anti-
bodies followed by horseradish peroxidase-conjugated protein A. CD4 protein
was detected with RM4.5 rat mAb (PharMingen) followed by horseradish
peroxidase-conjugated goat anti-rat antibodies. Reactivity was detected by
enhanced chemiluminescence.
Quantitative Real-Time PCR
Preselection DP (CD69-TCRbloCD4+CD8+) and intermediate (CD69+TCRbint/hi
CD4+CD8lo) thymocytes were obtained by electronic sorting of thymocyte
suspensions, and total RNA was immediately isolated with the RNEasy kit
(QIAGEN). RNA was reverse transcribed into cDNA by oligo(dT) priming with
the SuperScript III First Strand Synthesis System (Invitrogen). Quantitative
RT-PCR (qRT-PCR) was performed with an ABI PRISM 7900HT Sequence
Detection System and the SYBR Green detection system (QIAGEN) with the
following primers: Gata3 (F: 50-GTCCTCATCTCTTCACCTTCC-30; R: 50-GAG
TCCGCAGGCATTGCAAAG-30), Tox (F: 50-CAGGACCCCTACTATTGCAAC-30;
R: 50-GCAGGCCATTGTGATTCATGG-30), ThPOK (F: 50- ACATGAGGACCC
ACACTGGTG-30; 50-CTTCCTCTTCCTCCTCCTCAG-30), Runx3 (F: 50-GCGAC
ATGGCTTCCAACAGC-30; R: 50-CTTAGCGCGCCGCTGTTCTCGC-30), and
Actb (F: 50-GAGAGGGAAATCGTGCGTGA-30; R: 50-ACATCTGCTGGAAGGT
GGAC-30). Gene expression values were normalized to those of Actb (b-actin
gene) in the same sample.
SUPPLEMENTAL DATA
Supplemental Data include seven figures and one table and can be found
with this article online at http://www.cell.com/immunity/supplemental/
S1074-7613(09)00375-6.
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